Why is Tatva Chintan falling/rising?

As of 02-Jul, Tatva Chintan Pharma Chem Ltd's stock price is rising, currently at 1,000.00, reflecting an increase of 50.0 or 5.26%. The stock has shown strong performance today, outperforming its sector by 6.15% and reaching an intraday high of Rs 1009, which is a 6.21% increase. Over the past week, the stock has gained 6.25%, and over the past month, it has risen by 8.23%. Despite a year-to-date increase of 13.28%, the stock has experienced a decline of 11.68% over the past year. The company maintains a low Debt to Equity ratio, which is a positive factor contributing to its recent upward movement.
In the broader market context, Tatva Chintan's short-term performance significantly outpaces the benchmark Sensex, which has only risen by 0.79% over the past week. The stock's liquidity remains adequate for trading, although there has been a decline in investor participation, with delivery volume falling by 16.35% against the five-day average. This decline in participation may indicate some caution among investors despite the stock's positive price movement and strong returns compared to the benchmark. Overall, the combination of solid short-term performance and favorable financial metrics supports the stock's rise, even as broader market conditions remain mixed.